scispace - formally typeset
G

Grisel Lopez

Researcher at National Institutes of Health

Publications -  85
Citations -  5781

Grisel Lopez is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Parkinsonism & Glucocerebrosidase. The author has an hindex of 28, co-authored 73 publications receiving 4933 citations. Previous affiliations of Grisel Lopez include George Washington University.

Papers
More filters
Journal ArticleDOI

Genome-wide association study reveals genetic risk underlying Parkinson's disease

TL;DR: It is demonstrated that an unequivocal role for common genetic variants in the etiology of typical PD and population-specific genetic heterogeneity in this disease is suggested, and supporting evidence that common variation around LRRK2 modulates risk for PD is provided.
Journal ArticleDOI

The link between the GBA gene and parkinsonism

TL;DR: Identification of the pathological mechanisms underlying GBA-associated parkinsonism will improve the understanding of the genetics, pathophysiology, and treatment for both rare and common neurological diseases.
Journal ArticleDOI

A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy Bodies

Mike A. Nalls, +68 more
- 01 Jun 2013 - 
TL;DR: In this paper, the authors found a significant association between GBA1 mutation carrier status and DLB, with an odds ratio of 8.28 (95% CI, 4.78-14.88).
Journal ArticleDOI

Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease

Alexandra Beilina, +168 more
TL;DR: It is shown, using the specific example of Parkinson disease, that identification of protein–protein interactions can help determine the most likely candidate for several GWAS loci, and proposed that three different genes for PD have a common biological function.
Journal ArticleDOI

Transcranial Direct Current Stimulation for the Treatment of Parkinson’s Disease

TL;DR: In this paper, the authors investigated the efficacy of transcranial direct current stimulation (tDCS) in the treatment of Parkinson9s disease (PD) and found that tDCS improved gait by some measures for a short time and improved bradykinesia in both the on and off states for longer than 3 months.